Atteinte vasculaire et remodelage ventriculaire gauche dans la maladie de Fabry

Pierre Boutouyrie; Elie Mousseaux; Benjamin Cocheteux; Stéphane Laurent; Dominique P. Germain

doi:10.1051/medsci/20052111s30

Home

All issues

Volume 21 (Décembre 2005) Numéro spécial

Med Sci (Paris), 21 (2005) 30-32

References

Free Access

Issue		Med Sci (Paris) Volume 21, Décembre 2005 Métabolisme glucidolipidique et risque cardiovasculaire: Nouvelle approches


Page(s)		30 - 32
Section		M/S revues
DOI		https://doi.org/10.1051/medsci/20052111s30
Published online		15 November 2005

MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001; 38 : 769–75. [Google Scholar]
MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001; 38 : 750–60. [Google Scholar]
Germain DP. Fabry’s disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects. J Soc Biol 2002; 196 : 161–73. [Google Scholar]
Boutouyrie P, Laurent S, Laloux B, et al. Arterial remodelling in Fabry disease. Acta Paediatr 2002; 91 (suppl): 62–6. [Google Scholar]
Boutouyrie P, Laurent S, Laloux B, et al. Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. J Med Genet 2001; 38 : 629–31. [Google Scholar]
Elleder M, Bradova V, Smid F, et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry’s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 1990; 417 : 449–55. [Google Scholar]
Desnick RJ, Blieden LC, Sharp HL, et al. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation 1976; 54 : 818–25. [Google Scholar]
Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol 1998; 18: 1523–33. [Google Scholar]
Saba PS, Roman MJ, Pini R, et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22 : 1873–80. [Google Scholar]
Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19 : 1550–8. [Google Scholar]
Boutouyrie P, Laurent S, Girerd X, et al. Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension 1995; 25 : 651–9. [Google Scholar]
Fisher EA, Desnick RJ, Gordon RE, et al. Fabry disease: an unusual cause of severe coronary disease in a young man. Ann Intern Med 1992; 117 : 221–3. [Google Scholar]
Linhart A, Palecek T, Bultas J, et al. New insights in cardiac structural changes in patients with Fabry’s disease. Am Heart J 2000; 139 : 1101–8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.

[1] MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001; 38 : 769–75. [Google Scholar]

[2] MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001; 38 : 750–60. [Google Scholar]

[3] Germain DP. Fabry’s disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects. J Soc Biol 2002; 196 : 161–73. [Google Scholar]

[4] Boutouyrie P, Laurent S, Laloux B, et al. Arterial remodelling in Fabry disease. Acta Paediatr 2002; 91 (suppl): 62–6. [Google Scholar]

[5] Boutouyrie P, Laurent S, Laloux B, et al. Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. J Med Genet 2001; 38 : 629–31. [Google Scholar]

[6] Elleder M, Bradova V, Smid F, et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry’s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 1990; 417 : 449–55. [Google Scholar]

[7] Desnick RJ, Blieden LC, Sharp HL, et al. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation 1976; 54 : 818–25. [Google Scholar]

[8] Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol 1998; 18: 1523–33. [Google Scholar]

[9] Saba PS, Roman MJ, Pini R, et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22 : 1873–80. [Google Scholar]

[10] Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19 : 1550–8. [Google Scholar]

[11] Boutouyrie P, Laurent S, Girerd X, et al. Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension 1995; 25 : 651–9. [Google Scholar]

[12] Fisher EA, Desnick RJ, Gordon RE, et al. Fabry disease: an unusual cause of severe coronary disease in a young man. Ann Intern Med 1992; 117 : 221–3. [Google Scholar]

[13] Linhart A, Palecek T, Bultas J, et al. New insights in cardiac structural changes in patients with Fabry’s disease. Am Heart J 2000; 139 : 1101–8. [Google Scholar]